Executive Summary
Broadcom has staged a significant 6.84% recovery to $313.49 since the March 31 report, breaking an eight-session losing streak following robust Q1 earnings that exceeded expectations. The company's AI revenue more than doubled to $8.4 billion with management projecting at least $100 billion in AI chip revenue for fiscal 2027, prompting analysts to raise fair value estimates to $500. Despite this sharp rebound, shares remain 9.42% below year-to-date levels and approximately 25% below December 2025 highs, suggesting the recovery is in early stages.
Key Updates
Broadcom reversed its extended downtrend with a 6.84% gain following March 5 earnings that significantly beat expectations. Q1 revenue reached $19.31 billion (up 29% year-over-year), exceeding the $19.26 billion consensus, while adjusted EPS of $2.05 topped the $2.03 estimate. AI revenue doubled to $8.4 billion, driven by custom accelerators and networking solutions. Management's Q2 guidance of $22 billion substantially exceeded the $20.5 billion analyst estimate, representing approximately 30% sequential growth in AI chip revenue to $10.7 billion. The company authorized a new $10 billion share buyback program and analysts raised fair value estimates from $480 to $500 based on strengthened 2027 visibility.
Current Trend
The stock has transitioned from a pronounced downtrend to early-stage recovery. After declining 15.22% year-to-date through March 31 and establishing multi-month lows, shares rebounded 6.84% on strong earnings momentum. However, the YTD performance remains negative at -9.42%, and shares continue trading approximately 25% below December 2025 peaks. The 1-day gain of 1.29% suggests sustained buying interest, though 5-day (-1.67%) and 1-month (-1.67%) metrics indicate the recovery is recent. The 6-month decline of -5.97% establishes a clear resistance zone that must be overcome to confirm trend reversal. Current price of $313.49 represents a critical test of near-term resistance levels.
Investment Thesis
Broadcom's investment thesis centers on its dominant position as the second-largest custom AI chip provider after Nvidia, capturing accelerating demand from hyperscalers transitioning from training to deployment phases. The company serves major customers including Google and expects OpenAI to become its sixth hyperscaler customer with XPU deployments beginning in 2027. Management's projection of at least $100 billion in AI chip revenue for fiscal 2027 represents extraordinary growth visibility, supported by expanding customer base beyond traditional hyperscalers. The custom AI accelerator and networking solutions portfolio positions Broadcom at the intersection of AI infrastructure build-out, while the $10 billion buyback authorization demonstrates capital allocation discipline. With shares trading 25% below recent highs despite strengthening fundamentals, the thesis suggests significant upside to the $500 analyst fair value estimate.
Thesis Status
The investment thesis has strengthened materially since the March 31 report. Management's fiscal 2027 guidance of at least $100 billion in AI chip revenue provides unprecedented visibility and validates the AI growth trajectory. The addition of OpenAI as a sixth hyperscaler customer and 30% sequential growth projection for Q2 AI revenue demonstrate accelerating momentum beyond initial expectations. AI revenue doubling to $8.4 billion confirms Broadcom's competitive positioning in custom chips, while the transition from AI training to deployment phases expands the addressable market. The 6.84% price recovery partially closes the valuation gap to the $500 fair value estimate, though shares remain 37% below analyst targets. The $10 billion buyback authorization reinforces management confidence in long-term value creation. Previous concerns about the extended selloff appear disconnected from improving fundamentals, suggesting the thesis remains intact with enhanced conviction.
Key Drivers
AI revenue growth represents the dominant catalyst, with Q1 sales of $8.4 billion more than doubling year-over-year and Q2 guidance indicating 30% sequential acceleration to $10.7 billion. Management's projection of at least $100 billion in AI chip revenue for fiscal 2027 provides multi-year visibility into the growth trajectory. The Wall Street Journal reports customer base expansion beyond traditional hyperscalers as AI developers build more products and agents, broadening revenue diversification. OpenAI's anticipated emergence as the sixth major hyperscaler customer with XPU deployments beginning in 2027 adds significant incremental revenue potential. Morningstar notes Broadcom's dominant position in custom AI chips as second-largest player after Nvidia, serving Google with anticipated significant growth from Anthropic deployments. The $10 billion share buyback program signals management's view that current valuations represent attractive entry points relative to long-term prospects.
Technical Analysis
Broadcom executed a sharp reversal from oversold conditions, gaining 6.84% to $313.49 and breaking an eight-session losing streak. The stock established a multi-month low near $293 in late March before rebounding, creating a potential double-bottom formation if support holds. Current price remains 9.42% below year-to-date starting levels and approximately 25% below December 2025 highs near $418, establishing significant overhead resistance. The 1-day gain of 1.29% suggests momentum continuation, though 5-day and 1-month declines of -1.67% indicate the recovery is nascent. Volume patterns on the earnings-driven bounce suggest institutional participation. Key resistance exists at $325-$330 (previous support turned resistance) and $350 (6-month retracement level). Support has formed at $293-$295 (recent lows). The 6-month decline of -5.97% creates a downtrend line that requires sustained buying pressure to overcome. RSI likely recovered from oversold territory but remains below neutral, suggesting room for further upside before overbought conditions emerge.
Bull Case
- Management projects at least $100 billion in AI chip revenue for fiscal 2027, providing extraordinary multi-year growth visibility and validating Broadcom's position in the AI infrastructure build-out. Source: Morningstar
- AI revenue more than doubled to $8.4 billion in Q1 with Q2 guidance indicating 30% sequential growth to $10.7 billion, demonstrating accelerating momentum as customers transition from training to deployment phases. Source: Wall Street Journal
- Analysts raised fair value estimate to $500 from $480 based on stronger-than-expected 2027 guidance, implying 59% upside from current levels and suggesting shares remain significantly undervalued. Source: Morningstar
- OpenAI expected to become sixth major hyperscaler customer with XPU deployments beginning in 2027, adding significant incremental revenue from one of AI's most prominent players and diversifying customer concentration. Source: Wall Street Journal
- New $10 billion share buyback authorization demonstrates management confidence in long-term value creation and provides price support, particularly attractive given shares trading 25% below December 2025 highs. Source: Wall Street Journal
Bear Case
- Shares remain 9.42% below year-to-date levels despite strong earnings recovery, indicating persistent selling pressure and suggesting investors may be concerned about valuation or execution risks not evident in recent results. Source: Morningstar
- Stock trades approximately 25% below December 2025 highs near $418, establishing significant overhead resistance that may cap near-term upside as previous buyers seek exit opportunities at breakeven levels. Source: Morningstar
- Six-month decline of -5.97% and one-month decline of -1.67% demonstrate sustained negative momentum that preceded the earnings bounce, suggesting technical damage requiring extended consolidation before sustainable uptrend resumes. Source: Morningstar
- Heavy concentration in AI revenue creates execution risk if hyperscaler customers delay deployments or reduce capital expenditure, particularly as fiscal 2027 guidance of $100 billion represents aggressive growth targets requiring flawless execution. Source: Morningstar
- OpenAI XPU deployments not expected until 2027, creating extended timeline risk where competitive dynamics or technology shifts could impact anticipated revenue contribution from this sixth hyperscaler customer. Source: Wall Street Journal